Keyphrases
Randomized Placebo-controlled Trial
100%
Negative Syndrome
100%
Schizophrenia Spectrum Disorders
100%
Aspirin Therapy
100%
Aspirin
83%
Immune Function
50%
Antipsychotics
50%
Adjuvant Therapy
50%
Cognitive Tests
33%
Netherlands
16%
Placebo
16%
Efficacy Outcomes
16%
Cognitive Function
16%
Treatment Efficacy
16%
Randomized Double-blind Placebo-controlled Study
16%
Inflammation
16%
Psychopathology
16%
Drug Development
16%
DSM-IV
16%
Inflammatory Process
16%
Pathophysiology of Schizophrenia
16%
New Targets
16%
Mixed-effects Model
16%
Test Functions
16%
Subscale Scores
16%
Acetylsalicylic Acid
16%
3-month Follow-up
16%
Psychiatric Hospital
16%
Subscale Test
16%
Placebo Groups
16%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Acetylsalicylic Acid
100%
Schizophrenia Spectrum Disorder
100%
Negative Syndrome
85%
Positive Syndrome
85%
Antipsychotic
42%
Inflammation
28%
Pathophysiology
14%
Side Effect
14%
Placebo-Controlled Study
14%
Drug Development
14%
Combination Therapy
14%
DSM-IV
14%
INIS
therapy
100%
symptoms
100%
spectra
100%
aspirin
100%
patients
33%
inflammation
33%
reduction
16%
drugs
16%
comparative evaluations
16%
side effects
16%
assessments
16%
netherlands
16%
hospitals
16%
presses
16%
acetylsalicylic acid
16%
Neuroscience
Placebo
100%
Negative Syndrome
100%
Positive Syndrome
100%
Schizophrenia Spectrum Disorder
100%
Adjuvant Therapy
50%
Antipsychotic
50%
Cognitive Tests
33%
Cognitive Function
16%